Bend Research Adds to Oral and Inhalation Capabilities
Bend Research adds powder-filling technology.
Bend Research, part of Capsugel’s Dosage Form Solutions business unit, has added Capsugel’s Xcelodose powder-filling technology. The microdosing technology will help develop Bend Research’s recently announced Rapid Advancement of Preclinical Compounds initiative.
The Xcelodose 600S powder microdosing system enables the dispensing of dose weights as low as 100 micrograms, without excipients or bulking agents. The technology is used to prepare products for clinical trials and small-scale production.
The Xcelodose technology will have specific applications in Bend Research’s oral and inhalation product development.
Source: Bend Research
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
